

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.43855729 |
| 2 | vocalization behavior (GO:0071625) | 5.16501621 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.13404134 |
| 4 | locomotory exploration behavior (GO:0035641) | 4.91324532 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.90187473 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 4.85722660 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.85547210 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.83993295 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.78558250 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.66727982 |
| 11 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.64931889 |
| 12 | protein localization to synapse (GO:0035418) | 4.63175252 |
| 13 | glutamate secretion (GO:0014047) | 4.57162452 |
| 14 | neuronal action potential propagation (GO:0019227) | 4.50485558 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.36104500 |
| 16 | glutamate receptor signaling pathway (GO:0007215) | 4.35130432 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.33090268 |
| 18 | synaptic transmission, glutamatergic (GO:0035249) | 4.16065715 |
| 19 | gamma-aminobutyric acid transport (GO:0015812) | 4.06485352 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.01311226 |
| 21 | neuron-neuron synaptic transmission (GO:0007270) | 3.95744124 |
| 22 | cellular potassium ion homeostasis (GO:0030007) | 3.92704638 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.91728070 |
| 24 | exploration behavior (GO:0035640) | 3.90568736 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 3.88194788 |
| 26 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.87108376 |
| 27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.85410869 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 3.85182359 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.84419648 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.82792122 |
| 31 | nucleobase catabolic process (GO:0046113) | 3.81398121 |
| 32 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.81248779 |
| 33 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.79870231 |
| 34 | presynaptic membrane assembly (GO:0097105) | 3.78354142 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 3.75198734 |
| 36 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.72387978 |
| 37 | neuron recognition (GO:0008038) | 3.69790936 |
| 38 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.66913904 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.66317362 |
| 40 | presynaptic membrane organization (GO:0097090) | 3.65995546 |
| 41 | long-term memory (GO:0007616) | 3.63766932 |
| 42 | establishment of mitochondrion localization (GO:0051654) | 3.60178324 |
| 43 | cerebellar granule cell differentiation (GO:0021707) | 3.59397843 |
| 44 | regulation of synapse structural plasticity (GO:0051823) | 3.58136272 |
| 45 | postsynaptic membrane organization (GO:0001941) | 3.56738427 |
| 46 | transmission of nerve impulse (GO:0019226) | 3.55699000 |
| 47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.53490923 |
| 48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.52104212 |
| 49 | axon ensheathment in central nervous system (GO:0032291) | 3.50622990 |
| 50 | central nervous system myelination (GO:0022010) | 3.50622990 |
| 51 | positive regulation of membrane potential (GO:0045838) | 3.48267746 |
| 52 | neurotransmitter transport (GO:0006836) | 3.46587068 |
| 53 | proline transport (GO:0015824) | 3.42529752 |
| 54 | axonal fasciculation (GO:0007413) | 3.41298907 |
| 55 | dendrite morphogenesis (GO:0048813) | 3.40907762 |
| 56 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.40513454 |
| 57 | sodium ion export (GO:0071436) | 3.39985509 |
| 58 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.39729626 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.32068503 |
| 60 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.31199680 |
| 61 | positive regulation of synapse maturation (GO:0090129) | 3.29769530 |
| 62 | auditory behavior (GO:0031223) | 3.28037003 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.23353781 |
| 64 | membrane hyperpolarization (GO:0060081) | 3.23002503 |
| 65 | neuromuscular synaptic transmission (GO:0007274) | 3.22597015 |
| 66 | synaptic vesicle endocytosis (GO:0048488) | 3.21202053 |
| 67 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.19678747 |
| 68 | synapse assembly (GO:0007416) | 3.18402941 |
| 69 | response to auditory stimulus (GO:0010996) | 3.18194055 |
| 70 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.17922004 |
| 71 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.17693118 |
| 72 | cellular sodium ion homeostasis (GO:0006883) | 3.16866201 |
| 73 | L-amino acid import (GO:0043092) | 3.15912874 |
| 74 | regulation of synapse maturation (GO:0090128) | 3.14421945 |
| 75 | amino acid import (GO:0043090) | 3.13906320 |
| 76 | regulation of neurotransmitter levels (GO:0001505) | 3.13807485 |
| 77 | regulation of synaptic plasticity (GO:0048167) | 3.13254100 |
| 78 | * membrane depolarization during action potential (GO:0086010) | 3.12573609 |
| 79 | * membrane depolarization (GO:0051899) | 3.11413105 |
| 80 | * positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.10646776 |
| 81 | * membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.10460662 |
| 82 | regulation of vesicle fusion (GO:0031338) | 3.08931157 |
| 83 | adult walking behavior (GO:0007628) | 3.08725067 |
| 84 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.08471042 |
| 85 | mitochondrion transport along microtubule (GO:0047497) | 3.08471042 |
| 86 | central nervous system neuron axonogenesis (GO:0021955) | 3.08041023 |
| 87 | long-term synaptic potentiation (GO:0060291) | 3.07148049 |
| 88 | cell communication by electrical coupling (GO:0010644) | 3.06386639 |
| 89 | neuromuscular process controlling balance (GO:0050885) | 3.04510008 |
| 90 | cell migration in hindbrain (GO:0021535) | 3.03862216 |
| 91 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.02696404 |
| 92 | potassium ion import (GO:0010107) | 3.02440769 |
| 93 | neuromuscular process controlling posture (GO:0050884) | 3.01053803 |
| 94 | regulation of neurotransmitter transport (GO:0051588) | 3.00777576 |
| 95 | innervation (GO:0060384) | 2.99586896 |
| 96 | membrane assembly (GO:0071709) | 2.99042649 |
| 97 | learning (GO:0007612) | 2.95954512 |
| 98 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.95854206 |
| 99 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.95789165 |
| 100 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.94865931 |
| 101 | C4-dicarboxylate transport (GO:0015740) | 2.94857645 |
| 102 | activation of protein kinase A activity (GO:0034199) | 2.94534549 |
| 103 | mechanosensory behavior (GO:0007638) | 2.94345144 |
| 104 | positive regulation of dendritic spine development (GO:0060999) | 2.94299376 |
| 105 | glycine transport (GO:0015816) | 2.92751977 |
| 106 | cell differentiation in hindbrain (GO:0021533) | 2.92148401 |
| 107 | regulation of respiratory system process (GO:0044065) | 2.92032451 |
| 108 | positive regulation of synapse assembly (GO:0051965) | 2.91219820 |
| 109 | neuronal ion channel clustering (GO:0045161) | 2.90663948 |
| 110 | response to histamine (GO:0034776) | 2.90031906 |
| 111 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.87795738 |
| 112 | prepulse inhibition (GO:0060134) | 2.87554921 |
| 113 | synapse organization (GO:0050808) | 2.86575511 |
| 114 | synaptic transmission (GO:0007268) | 2.86294115 |
| 115 | regulation of dendritic spine development (GO:0060998) | 2.84709470 |
| 116 | mating behavior (GO:0007617) | 2.82453320 |
| 117 | startle response (GO:0001964) | 2.80346932 |
| 118 | potassium ion homeostasis (GO:0055075) | 2.78927450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.74549584 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.82684936 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.04159241 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99135366 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96043492 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62444940 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62444940 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50915120 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50825700 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48776948 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46661487 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46289481 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42005298 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41701600 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37045380 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33291781 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30955430 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16247005 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11944144 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10827953 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.10428761 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.05629206 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.00965894 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.00783560 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94767613 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89208339 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.88350887 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.78405045 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75314400 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72443059 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71576075 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71273569 |
| 33 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70174190 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.66843928 |
| 35 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63551394 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56079036 |
| 37 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.54040374 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50681424 |
| 39 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.49222359 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45286342 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44109945 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41772704 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40779792 |
| 44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40748743 |
| 45 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40086803 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39461393 |
| 47 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.35732507 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35586076 |
| 49 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35456256 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35121062 |
| 51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34205428 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33041697 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32892729 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31449490 |
| 55 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.31253166 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30657551 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.30287424 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29610717 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29570630 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29443018 |
| 61 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28927559 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27604139 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26363709 |
| 64 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23030873 |
| 65 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16871061 |
| 66 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16510253 |
| 67 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16138454 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15747117 |
| 69 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15233010 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14846960 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12362441 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12229684 |
| 73 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.11425111 |
| 74 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08672092 |
| 75 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08443833 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07724929 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07381695 |
| 78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07285712 |
| 79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07275831 |
| 80 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06664784 |
| 81 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04924040 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04214583 |
| 83 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03905393 |
| 84 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03558872 |
| 85 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03071664 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03011926 |
| 87 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02872304 |
| 88 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02825126 |
| 89 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02730189 |
| 90 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02638219 |
| 91 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.02538511 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02009005 |
| 93 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.01776658 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01058782 |
| 95 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00877342 |
| 96 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00600757 |
| 97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00176150 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00158254 |
| 99 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99475321 |
| 100 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99475321 |
| 101 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98920579 |
| 102 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95390673 |
| 103 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95287751 |
| 104 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95246595 |
| 105 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.94705663 |
| 106 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93923023 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93688850 |
| 108 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92827409 |
| 109 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91613345 |
| 110 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90497862 |
| 111 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90226286 |
| 112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90082294 |
| 113 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86424824 |
| 114 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85856604 |
| 115 | JUN_21703547_ChIP-Seq_K562_Human | 0.85787934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.52434778 |
| 2 | MP0003880_abnormal_central_pattern | 4.50297252 |
| 3 | MP0004270_analgesia | 3.87050029 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.82559986 |
| 5 | MP0009046_muscle_twitch | 3.28735243 |
| 6 | MP0009745_abnormal_behavioral_response | 3.22893536 |
| 7 | MP0002064_seizures | 3.05780471 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.03717673 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.01127646 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.00206549 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.79832004 |
| 12 | MP0002272_abnormal_nervous_system | 2.71607386 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.69341909 |
| 14 | MP0001486_abnormal_startle_reflex | 2.64779126 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.54162363 |
| 16 | MP0002736_abnormal_nociception_after | 2.36843872 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.25013462 |
| 18 | MP0002822_catalepsy | 2.22614763 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.15671668 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.13503543 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.12158633 |
| 22 | MP0001970_abnormal_pain_threshold | 2.05606578 |
| 23 | MP0008569_lethality_at_weaning | 2.03421464 |
| 24 | * MP0000778_abnormal_nervous_system | 1.97489057 |
| 25 | MP0002184_abnormal_innervation | 1.95342810 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.89096688 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.80069166 |
| 28 | MP0004924_abnormal_behavior | 1.80069166 |
| 29 | MP0003329_amyloid_beta_deposits | 1.79402475 |
| 30 | MP0004858_abnormal_nervous_system | 1.75945157 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.73253196 |
| 32 | MP0000955_abnormal_spinal_cord | 1.63594230 |
| 33 | MP0001984_abnormal_olfaction | 1.62792327 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.57137146 |
| 35 | MP0001529_abnormal_vocalization | 1.56580074 |
| 36 | MP0004885_abnormal_endolymph | 1.54337935 |
| 37 | MP0004142_abnormal_muscle_tone | 1.54122366 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.52458940 |
| 39 | * MP0002882_abnormal_neuron_morphology | 1.51532510 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.49105331 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.44901397 |
| 42 | MP0001905_abnormal_dopamine_level | 1.42237567 |
| 43 | * MP0002066_abnormal_motor_capabilities/c | 1.41640049 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.40104829 |
| 45 | MP0003633_abnormal_nervous_system | 1.34593958 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.34396785 |
| 47 | MP0001188_hyperpigmentation | 1.33732498 |
| 48 | MP0000920_abnormal_myelination | 1.28594414 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.28142101 |
| 50 | MP0004742_abnormal_vestibular_system | 1.26562858 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.25329126 |
| 52 | MP0003879_abnormal_hair_cell | 1.23949883 |
| 53 | MP0002229_neurodegeneration | 1.22549945 |
| 54 | MP0003631_nervous_system_phenotype | 1.21271249 |
| 55 | MP0000751_myopathy | 1.18246324 |
| 56 | * MP0002152_abnormal_brain_morphology | 1.11882857 |
| 57 | MP0003634_abnormal_glial_cell | 1.11058646 |
| 58 | MP0003787_abnormal_imprinting | 1.09309357 |
| 59 | MP0003690_abnormal_glial_cell | 1.09123629 |
| 60 | MP0002638_abnormal_pupillary_reflex | 1.08254373 |
| 61 | MP0003122_maternal_imprinting | 1.03689594 |
| 62 | MP0003632_abnormal_nervous_system | 1.02786886 |
| 63 | MP0005409_darkened_coat_color | 0.98518167 |
| 64 | MP0003121_genomic_imprinting | 0.98085410 |
| 65 | MP0010386_abnormal_urinary_bladder | 0.97610580 |
| 66 | * MP0002752_abnormal_somatic_nervous | 0.97348214 |
| 67 | MP0004215_abnormal_myocardial_fiber | 0.94718336 |
| 68 | MP0001963_abnormal_hearing_physiology | 0.93402370 |
| 69 | MP0005187_abnormal_penis_morphology | 0.91423478 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 0.90819433 |
| 71 | MP0005171_absent_coat_pigmentation | 0.89568045 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 0.87228810 |
| 73 | MP0003123_paternal_imprinting | 0.86473045 |
| 74 | * MP0004085_abnormal_heartbeat | 0.84728577 |
| 75 | MP0001485_abnormal_pinna_reflex | 0.84607583 |
| 76 | MP0002069_abnormal_eating/drinking_beha | 0.83365939 |
| 77 | MP0002090_abnormal_vision | 0.82494121 |
| 78 | MP0000569_abnormal_digit_pigmentation | 0.81955223 |
| 79 | MP0001177_atelectasis | 0.81774204 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.81611022 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 0.79634198 |
| 82 | MP0005253_abnormal_eye_physiology | 0.78194525 |
| 83 | MP0002751_abnormal_autonomic_nervous | 0.74356693 |
| 84 | MP0008874_decreased_physiological_sensi | 0.74160154 |
| 85 | MP0005499_abnormal_olfactory_system | 0.73785137 |
| 86 | MP0005394_taste/olfaction_phenotype | 0.73785137 |
| 87 | MP0004130_abnormal_muscle_cell | 0.73288963 |
| 88 | * MP0003137_abnormal_impulse_conducting | 0.72586468 |
| 89 | MP0004484_altered_response_of | 0.69896996 |
| 90 | MP0000604_amyloidosis | 0.68829295 |
| 91 | MP0004043_abnormal_pH_regulation | 0.67270944 |
| 92 | MP0005535_abnormal_body_temperature | 0.67025294 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.66273624 |
| 94 | * MP0008872_abnormal_physiological_respon | 0.65798894 |
| 95 | * MP0010768_mortality/aging | 0.63336921 |
| 96 | MP0001943_abnormal_respiration | 0.61926754 |
| 97 | MP0003861_abnormal_nervous_system | 0.61077969 |
| 98 | MP0000026_abnormal_inner_ear | 0.60126699 |
| 99 | MP0000749_muscle_degeneration | 0.59555179 |
| 100 | MP0002081_perinatal_lethality | 0.59342630 |
| 101 | MP0004233_abnormal_muscle_weight | 0.59339168 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.59002002 |
| 103 | MP0001986_abnormal_taste_sensitivity | 0.58975157 |
| 104 | MP0005248_abnormal_Harderian_gland | 0.58593223 |
| 105 | MP0000566_synostosis | 0.58457509 |
| 106 | MP0004147_increased_porphyrin_level | 0.58013609 |
| 107 | MP0000747_muscle_weakness | 0.57275987 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.55253242 |
| 109 | * MP0010769_abnormal_survival | 0.54740366 |
| 110 | MP0002234_abnormal_pharynx_morphology | 0.54364944 |
| 111 | MP0008877_abnormal_DNA_methylation | 0.54341148 |
| 112 | MP0003646_muscle_fatigue | 0.54129334 |
| 113 | * MP0010770_preweaning_lethality | 0.53730218 |
| 114 | * MP0002082_postnatal_lethality | 0.53730218 |
| 115 | MP0005620_abnormal_muscle_contractility | 0.52837032 |
| 116 | MP0003938_abnormal_ear_development | 0.51938364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.11934657 |
| 2 | Myokymia (HP:0002411) | 6.20324632 |
| 3 | Focal seizures (HP:0007359) | 5.45416610 |
| 4 | Progressive cerebellar ataxia (HP:0002073) | 4.74330162 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.69532495 |
| 6 | Visual hallucinations (HP:0002367) | 4.53332945 |
| 7 | Atonic seizures (HP:0010819) | 4.38204545 |
| 8 | Action tremor (HP:0002345) | 4.36213774 |
| 9 | Febrile seizures (HP:0002373) | 4.30004312 |
| 10 | Absence seizures (HP:0002121) | 3.87633776 |
| 11 | Broad-based gait (HP:0002136) | 3.77758853 |
| 12 | Dialeptic seizures (HP:0011146) | 3.65187559 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.60681851 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.59385400 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.56129902 |
| 16 | Dysdiadochokinesis (HP:0002075) | 3.30397036 |
| 17 | Dysmetria (HP:0001310) | 3.22819070 |
| 18 | Ankle clonus (HP:0011448) | 3.22231071 |
| 19 | Hyperventilation (HP:0002883) | 3.21576601 |
| 20 | Truncal ataxia (HP:0002078) | 3.16373026 |
| 21 | Scanning speech (HP:0002168) | 3.02393845 |
| 22 | Abnormality of the corticospinal tract (HP:0002492) | 3.00130738 |
| 23 | Hemiparesis (HP:0001269) | 2.96029019 |
| 24 | Neurofibrillary tangles (HP:0002185) | 2.94526531 |
| 25 | Poor eye contact (HP:0000817) | 2.89673271 |
| 26 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.86691777 |
| 27 | Genetic anticipation (HP:0003743) | 2.84336063 |
| 28 | Depression (HP:0000716) | 2.78832536 |
| 29 | Excessive salivation (HP:0003781) | 2.78164740 |
| 30 | Drooling (HP:0002307) | 2.78164740 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.77143153 |
| 32 | Amblyopia (HP:0000646) | 2.75999430 |
| 33 | Insidious onset (HP:0003587) | 2.73538965 |
| 34 | Termporal pattern (HP:0011008) | 2.73538965 |
| 35 | Spastic gait (HP:0002064) | 2.72221710 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.72054208 |
| 37 | Diplopia (HP:0000651) | 2.71763678 |
| 38 | Abnormality of binocular vision (HP:0011514) | 2.71763678 |
| 39 | Anxiety (HP:0000739) | 2.69165309 |
| 40 | Mutism (HP:0002300) | 2.67952093 |
| 41 | Postural instability (HP:0002172) | 2.63953117 |
| 42 | Pheochromocytoma (HP:0002666) | 2.63946493 |
| 43 | Cerebral inclusion bodies (HP:0100314) | 2.63564317 |
| 44 | Impaired social interactions (HP:0000735) | 2.61822427 |
| 45 | Abnormal social behavior (HP:0012433) | 2.61822427 |
| 46 | Intention tremor (HP:0002080) | 2.58173205 |
| 47 | Limb dystonia (HP:0002451) | 2.56143647 |
| 48 | Progressive inability to walk (HP:0002505) | 2.46984225 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.45847790 |
| 50 | Hemiplegia (HP:0002301) | 2.42498045 |
| 51 | Urinary urgency (HP:0000012) | 2.41357049 |
| 52 | Absent speech (HP:0001344) | 2.39807434 |
| 53 | Epileptiform EEG discharges (HP:0011182) | 2.36759141 |
| 54 | Megalencephaly (HP:0001355) | 2.36205316 |
| 55 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.34235157 |
| 56 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.34235157 |
| 57 | EEG with generalized epileptiform discharges (HP:0011198) | 2.26958643 |
| 58 | Neuroendocrine neoplasm (HP:0100634) | 2.24692075 |
| 59 | Lower limb muscle weakness (HP:0007340) | 2.23902531 |
| 60 | Hepatoblastoma (HP:0002884) | 2.20012538 |
| 61 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.19098869 |
| 62 | Dysmetric saccades (HP:0000641) | 2.18913238 |
| 63 | Blue irides (HP:0000635) | 2.14863594 |
| 64 | Polyphagia (HP:0002591) | 2.14404627 |
| 65 | Hypsarrhythmia (HP:0002521) | 2.10646301 |
| 66 | Fetal akinesia sequence (HP:0001989) | 2.10243131 |
| 67 | Amyotrophic lateral sclerosis (HP:0007354) | 2.09796626 |
| 68 | Bradykinesia (HP:0002067) | 2.09013547 |
| 69 | Papilledema (HP:0001085) | 2.08712774 |
| 70 | Agitation (HP:0000713) | 2.06060469 |
| 71 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.04908111 |
| 72 | Torticollis (HP:0000473) | 2.04600461 |
| 73 | Stereotypic behavior (HP:0000733) | 2.04387836 |
| 74 | Aplasia involving bones of the extremities (HP:0009825) | 2.02911856 |
| 75 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.02911856 |
| 76 | Aplasia of the phalanges of the hand (HP:0009802) | 2.02911856 |
| 77 | Sleep apnea (HP:0010535) | 2.01895388 |
| 78 | Inability to walk (HP:0002540) | 2.00576688 |
| 79 | Peripheral hypomyelination (HP:0007182) | 1.99819982 |
| 80 | Tetraplegia (HP:0002445) | 1.98749192 |
| 81 | Gait imbalance (HP:0002141) | 1.97684762 |
| 82 | Status epilepticus (HP:0002133) | 1.96186146 |
| 83 | Retinal dysplasia (HP:0007973) | 1.93693313 |
| 84 | Gait ataxia (HP:0002066) | 1.93504002 |
| 85 | Abnormality of salivation (HP:0100755) | 1.92498057 |
| 86 | Generalized myoclonic seizures (HP:0002123) | 1.92294357 |
| 87 | Impaired vibratory sensation (HP:0002495) | 1.91022746 |
| 88 | Obstructive sleep apnea (HP:0002870) | 1.90391104 |
| 89 | Specific learning disability (HP:0001328) | 1.88940018 |
| 90 | Spastic tetraplegia (HP:0002510) | 1.88564360 |
| 91 | Spastic tetraparesis (HP:0001285) | 1.88091093 |
| 92 | Ventricular fibrillation (HP:0001663) | 1.87856486 |
| 93 | Hypoplasia of the corpus callosum (HP:0002079) | 1.87440213 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 1.86863529 |
| 95 | Abnormality of the lower motor neuron (HP:0002366) | 1.86496442 |
| 96 | Focal dystonia (HP:0004373) | 1.86111003 |
| 97 | Clumsiness (HP:0002312) | 1.84219706 |
| 98 | Aqueductal stenosis (HP:0002410) | 1.84039476 |
| 99 | Abnormality of saccadic eye movements (HP:0000570) | 1.83638994 |
| 100 | Inappropriate behavior (HP:0000719) | 1.83283550 |
| 101 | Psychosis (HP:0000709) | 1.80361860 |
| 102 | Postural tremor (HP:0002174) | 1.80071466 |
| 103 | Protruding tongue (HP:0010808) | 1.79720417 |
| 104 | Bundle branch block (HP:0011710) | 1.78785487 |
| 105 | Incomplete penetrance (HP:0003829) | 1.78111825 |
| 106 | Clonus (HP:0002169) | 1.76938023 |
| 107 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.75827709 |
| 108 | Hypoplasia of the brainstem (HP:0002365) | 1.75827709 |
| 109 | Akinesia (HP:0002304) | 1.75062365 |
| 110 | Sudden death (HP:0001699) | 1.74646211 |
| 111 | Onion bulb formation (HP:0003383) | 1.73123709 |
| 112 | Cutaneous finger syndactyly (HP:0010554) | 1.71966876 |
| 113 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.71637242 |
| 114 | Intellectual disability, severe (HP:0010864) | 1.71416725 |
| 115 | Craniofacial dystonia (HP:0012179) | 1.69029463 |
| 116 | Split foot (HP:0001839) | 1.68806639 |
| 117 | Thickened helices (HP:0000391) | 1.66708946 |
| 118 | Difficulty running (HP:0009046) | 1.65889947 |
| 119 | Paraplegia (HP:0010550) | 1.64303307 |
| 120 | Hammertoe (HP:0001765) | 1.64251458 |
| 121 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.61495943 |
| 122 | Pachygyria (HP:0001302) | 1.60158526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.16867296 |
| 2 | MARK1 | 3.54792625 |
| 3 | EPHA4 | 3.34469734 |
| 4 | MAP3K9 | 3.03913593 |
| 5 | MAP3K4 | 3.01499791 |
| 6 | CASK | 2.83278868 |
| 7 | MAP2K7 | 2.57547836 |
| 8 | MINK1 | 2.49778430 |
| 9 | NTRK2 | 2.38671047 |
| 10 | TNIK | 2.25444468 |
| 11 | PAK6 | 2.11496866 |
| 12 | NTRK1 | 2.06578923 |
| 13 | DAPK2 | 1.96114234 |
| 14 | PNCK | 1.90405321 |
| 15 | MAPK13 | 1.76496393 |
| 16 | MAP2K4 | 1.69678849 |
| 17 | PHKG2 | 1.67698767 |
| 18 | PHKG1 | 1.67698767 |
| 19 | CCNB1 | 1.66588108 |
| 20 | MAP3K12 | 1.50448876 |
| 21 | CDK5 | 1.48849338 |
| 22 | RIPK4 | 1.47528722 |
| 23 | PRPF4B | 1.43868263 |
| 24 | CDK19 | 1.38092782 |
| 25 | KSR2 | 1.37698274 |
| 26 | PRKD3 | 1.35396923 |
| 27 | CAMKK1 | 1.34385505 |
| 28 | PLK2 | 1.31451026 |
| 29 | GRK5 | 1.30981780 |
| 30 | OXSR1 | 1.29959048 |
| 31 | CAMKK2 | 1.27564620 |
| 32 | UHMK1 | 1.26353518 |
| 33 | SGK223 | 1.23408671 |
| 34 | SGK494 | 1.23408671 |
| 35 | KSR1 | 1.23036444 |
| 36 | CAMK2A | 1.15886344 |
| 37 | PRKCG | 1.14815854 |
| 38 | STK38 | 1.13240677 |
| 39 | STK39 | 1.08842192 |
| 40 | CAMK2B | 1.08318326 |
| 41 | SIK2 | 1.06938124 |
| 42 | WNK1 | 1.06469706 |
| 43 | DAPK1 | 0.97750965 |
| 44 | FES | 0.95253319 |
| 45 | TYRO3 | 0.94324027 |
| 46 | CSNK1G2 | 0.93487980 |
| 47 | SGK2 | 0.90799771 |
| 48 | LMTK2 | 0.90533809 |
| 49 | MUSK | 0.90183832 |
| 50 | CDK18 | 0.88087727 |
| 51 | CDK15 | 0.86460518 |
| 52 | PAK3 | 0.85874418 |
| 53 | CAMK1 | 0.85167889 |
| 54 | CDK14 | 0.84271348 |
| 55 | STK11 | 0.84227613 |
| 56 | CAMK2D | 0.83316075 |
| 57 | FRK | 0.82935632 |
| 58 | CAMK1G | 0.81467058 |
| 59 | MARK2 | 0.80917858 |
| 60 | DYRK1A | 0.80629257 |
| 61 | PKN1 | 0.80288115 |
| 62 | OBSCN | 0.77514898 |
| 63 | MAP3K2 | 0.75278649 |
| 64 | CDK11A | 0.74668390 |
| 65 | RET | 0.73791165 |
| 66 | SGK1 | 0.73674176 |
| 67 | PINK1 | 0.71653207 |
| 68 | PRKCH | 0.71438506 |
| 69 | PRKCE | 0.71433843 |
| 70 | LATS2 | 0.70424846 |
| 71 | NEK6 | 0.69267276 |
| 72 | ARAF | 0.68796796 |
| 73 | BCR | 0.68766283 |
| 74 | PTK2B | 0.67527735 |
| 75 | SGK3 | 0.66660003 |
| 76 | MAPKAPK5 | 0.66624521 |
| 77 | CAMK2G | 0.66555303 |
| 78 | FGR | 0.64516599 |
| 79 | FGFR2 | 0.64172439 |
| 80 | ROCK2 | 0.62513897 |
| 81 | BMPR2 | 0.62180691 |
| 82 | EPHA3 | 0.60554598 |
| 83 | MAP3K13 | 0.58981892 |
| 84 | GRK7 | 0.58498307 |
| 85 | CDC42BPA | 0.55464438 |
| 86 | CSNK1G1 | 0.55064436 |
| 87 | CSNK1G3 | 0.48285126 |
| 88 | ROCK1 | 0.48181072 |
| 89 | PRKCZ | 0.47884448 |
| 90 | * RPS6KA3 | 0.47817030 |
| 91 | PRKG1 | 0.47674299 |
| 92 | CSNK1D | 0.47443561 |
| 93 | FYN | 0.47435761 |
| 94 | WNK3 | 0.46616772 |
| 95 | PDPK1 | 0.46142871 |
| 96 | PDK1 | 0.43678442 |
| 97 | WNK4 | 0.43540880 |
| 98 | EPHB2 | 0.43386503 |
| 99 | RIPK1 | 0.43285273 |
| 100 | MAPK10 | 0.42406528 |
| 101 | CAMK4 | 0.40958984 |
| 102 | ERBB2 | 0.40784888 |
| 103 | NME1 | 0.39761204 |
| 104 | AKT3 | 0.39631594 |
| 105 | PRKACA | 0.39320261 |
| 106 | ADRBK1 | 0.38942277 |
| 107 | FER | 0.38814369 |
| 108 | CSNK1A1L | 0.38670153 |
| 109 | DYRK2 | 0.38492919 |
| 110 | MAPK12 | 0.38450282 |
| 111 | MAP4K2 | 0.36624822 |
| 112 | BMPR1B | 0.34105913 |
| 113 | MAPK4 | 0.33393331 |
| 114 | PRKDC | 0.32375342 |
| 115 | * GSK3B | 0.31592372 |
| 116 | CSNK1A1 | 0.31380359 |
| 117 | PRKACB | 0.30867613 |
| 118 | MKNK2 | 0.30767765 |
| 119 | CAMK1D | 0.29429216 |
| 120 | * CSNK1E | 0.28997195 |
| 121 | * PRKCB | 0.28918493 |
| 122 | ALK | 0.28914446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.91710980 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.02757437 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.76572128 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75707589 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.73200015 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.67811401 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.51858640 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.47521309 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.46934743 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.29148312 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.18592643 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10129146 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.08181002 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.99230480 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.98174304 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88534606 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84805957 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.83506253 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.82888001 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69020415 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.66830170 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.65732306 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.63592657 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.59552033 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52613109 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.45157267 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.40660063 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35665413 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.32079842 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31948857 |
| 31 | Axon guidance_Homo sapiens_hsa04360 | 1.31309453 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29997957 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28222375 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28182046 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.25588486 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25333681 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24058432 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13613341 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12026648 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07434784 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02399732 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02190734 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99935936 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 0.99373394 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99030177 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93493772 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93092222 |
| 48 | Glioma_Homo sapiens_hsa05214 | 0.87296582 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.87030472 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86176611 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84726494 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83757049 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80122291 |
| 54 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77160693 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76654802 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75572147 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70328689 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70319334 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70017730 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68737966 |
| 61 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64736585 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64729677 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64721261 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64680954 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61358343 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60427004 |
| 67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59488765 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58413066 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56449904 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56159989 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53771351 |
| 72 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53493606 |
| 73 | Tight junction_Homo sapiens_hsa04530 | 0.52123640 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51708125 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50574401 |
| 76 | Alcoholism_Homo sapiens_hsa05034 | 0.50488510 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49896560 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49278600 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.48645256 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48134035 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47879558 |
| 82 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46869041 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46695653 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45605196 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44878608 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44298050 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43196740 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42129968 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41862378 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40947647 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40310416 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38950441 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38470122 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.38332167 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36841889 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36825833 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36678721 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35472722 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.35343024 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34005920 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33887273 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33621168 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33518655 |
| 104 | Parkinsons disease_Homo sapiens_hsa05012 | 0.33456220 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32870619 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.32823144 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32628138 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32094211 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30068505 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29090525 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28915456 |
| 112 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.28504153 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27577276 |

